nach oben

Erschienen in:

01.05.2020 | Case report

Pembrolizumab

Acute kidney injury secondary to acute interstitial nephritis and autoimmune encephalopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Auszug

A 70-year-old man developed acute kidney injury (AKI) secondary to acute interstitial nephritis (AIN) following treatment with pembrolizumab. Additionally he developed autoimmune encephalopathy during treatment with pembrolizumab for basal cell carcinoma and urothelial cancer. …

Marvania N, et al. A RARE CASE OF ACUTE INTERSTITIAL NEPHRITIS DUE TO PEMBROLIZUMAB WHILE ON PRENDIONSE TAPER FOR AUTOIMMUNE ENCEPHALOPATHY. American Journal of Kidney Diseases 75: 605 abstr. 240, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1053/j.ajkd.2020.02.242 [abstract]

Titel: Pembrolizumab
Acute kidney injury secondary to acute interstitial nephritis and autoimmune encephalopathy: case report
Publikationsdatum: 01.05.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78949-5

Springer Medizin

Pembrolizumab

Acute kidney injury secondary to acute interstitial nephritis and autoimmune encephalopathy: case report

Auszug

Weitere Artikel der Ausgabe 1/2020

Heparin/tissue-plasminogen-activator

Ifosfamide

Valaciclovir overdose

Ustekinumab

Cemiplimab

Dutasteride

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Heparin/tissue-plasminogen-activator

Ifosfamide

Valaciclovir overdose

Ustekinumab

Cemiplimab

Dutasteride